CHAPTER IV
WORLD MARKET DATA
1. Top Branded Pharmaceuticals Worldwide
1998 worldwide sales in $ millions
Rank |
1997 Rank |
Brand
|
Company |
% Market Share(E) |
1997 |
1998 (E) |
1 |
1 |
Zocor (simvastatin) |
Merck |
31 |
3575 |
3926 |
2 |
2 |
Losec (omeprazole) |
Astra |
NA |
2845 |
3083 |
3 |
3 |
Prozac (fluoxetine) |
Lilly |
33 |
2559 |
2651 |
2. Leading Companies in 1998 Global Pharmaceutical Sales
Rank |
Company |
1998 Sales US $ billions |
% of Global Sales |
% Growth year over year |
1 |
Novartis |
10.6 |
4.2 |
+5 |
2 |
Merck & Co. |
10.6 |
4.2 |
+8 |
3 |
Glaxo Wellcome |
10.5 |
4.2 |
+1 |
3. Pharmaceutical Companies in 1998 Global FT500
Rank 1998 |
Rank 1997 |
Company |
Market Capitalisation (US $ million) |
5 |
8 |
Merck & Co |
154753 |
6 |
22 |
Pfizer |
148074 |
13 |
10 |
Novartis |
108475 |
4. Leading Therapy Classes in 1998 Global Pharmaceutical Sales
Rank |
Company |
1998 Sales US $ billions |
% of Global Sales |
% Growth year over year |
1 |
Anti-ulcerants |
12.9 |
5.1 |
+3 |
2 |
Cholesterol & triglyceride reducers |
9.6 |
3.8 |
+20 |
3 |
Antidepressants |
9.4 |
3.7 |
+21 |
Country |
Year to March 1998 |
% Change2 |
North
America |
72.9 |
+11 |
US |
68.7 |
+11 |
Canada |
4.2 |
+11 |
6. World's Most Profitable Companies
RANK |
COMPANY |
PROFIT (1995) |
1 |
Merck |
3335 |
2 |
Johnson & Johnson |
2403 |
3 |
Eli Lilly |
2291 |
Product
|
Originator |
Activity / indication |
17-1A MAb (Panorex) |
Centocor (US) |
Antibody/adjuvant for colorectal cancer |
Abeciximab (ReoPro) |
Centocor (US) |
Antiplatelet antibody/angioplasty |
Aimmugen |
Fujisawa (Japan) |
Hepatitis A vaccine |
8. Patent
Expiry Dates of Some Drugs and Pharmaceuticals
GENERIC NAME |
PATENT EXPIRY DATE |
Abciximab |
2015 |
Alandronate
Sodium |
2007 |
Alemtuzumb |
2015 |
Chapter I | Chapter II | Chapter III | Chapter IV | Chapter V | Chapter VI | Chapter VII | Chapter VIII | Chapter IX | Home
Website
Development & Search Engine Optimisation by : Aditya Infotech
Directory of Indian Manufacturers, Suppliers
and Products : easy2source.com